Beyond the Monoamine Hypothesis: Targeting Glutamate Signaling in Major Depressive Disorder
This presentation will include an overview of major depressive disorder, current treatment landscape, limitations and unmet needs, and the glutamate system as a new therapeutic target for depression. This educational presentation is intended for any practitioners in behavioral health, including non-specialists.